At Concept Life Sciences we are proud to offer extensive biophysical assay expertise which complements our existing capabilities in pharmaceutical discovery and development.
As a result of our ongoing work and extensive research, we are pleased to announce that our Head of Bioassay Development and Screening, Dr Andrew Scott has written a chapter in the RSC publication, “Biophysical Techniques in Drug Discovery”
Dr Scott’s chapter, titled “Fluorescent Thermal Shift Assays for Identifying Small Molecule Ligands,” highlights the important application of thermal shift assays, and other related biophysical techniques, in the discovery of both small and large molecule therapeutics. These assays can be used for screening compounds, including fragments, and as tools for more in-depth mode of action studies.
To read more about Andrew’s interesting chapter, please click here.